Customized research for FBIO vs. IMUC!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for FBIO vs. IMUC.


↗ Join Our Free Email Newsletter.




Fortress Biotech, Inc. vs. ImmunoCellular Therapeutics, Ltd.

Industry Match! Industry of Both FBIO and IMUC:

Health Care/Life Sciences

FBIO
Data Last Updated: More than 3 wks ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 101.107M


P/E: N/A

P/S: 3.76

Q P/B: 4.86

Y Rev: 26.88M

Q Rev: 6.48M

Beta: 4.08

FBIO Share Stats

Outstanding Shares

65.23M

Float Shares

33.07M

Percent of Float Short

9.29%

FBIO Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

FBIO Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

FBIO in Pulse Portal

Stream of Posts

FBIO Symbol Page

Share FBIO Insights

Express Sentiment

'Buy' or 'Sell' FBIO

FBIO Profile

CEO

Dr. Lindsay Allan Rosenwald

Exchange

Nasdaq

Employees

88.00

About

Fortress Biotech, Inc. engages in the development and commercialization of novel pharmaceutical and biotechnology products. It operates through the following segments: Dermatology Product Sales, Pharmaceutical and Biotechnology Product Development, and National. The...

FBIO Financials

Annual Financials

Income Statement

Revenue

26.88M

Net Income

(130.8M)

Cash Flow Statement

Change in Cash / Investments

(29.38M)

Balance Sheet

Cash / Investments

83.11M

Short Term Debt

None

Long Term Debt

60.43M

Total Current Assets

111.21M

Total Current Liabilities

55.61M

Total Assets

140.99M

Total Liabilities

121.25M

Stockholder Equity

1.85M

Quarterly Financials

Income Statement

Q Revenue

6.48M

Q Net Income

(16.26M)

Cash Flow Statement

Q Change in Cash / Investments

50.94M

Balance Sheet

Q Cash / Investments

121.49M

Q Short Term Debt

1.48M

Q Long Term Debt

73.61M

Q Total Current Assets

136.55M

Q Total Current Liabilities

48.96M

Q Total Assets

200.54M

Q Total Liabilities

149.83M

Q Stockholder Equity

20.82M

FBIO Charts

10-Year Chart

FBIO 10-Year Chart

5-Year Chart

FBIO 5-Year Chart

1-Year Chart

FBIO 1-Year Chart

6-Month Chart

FBIO 6-Month Chart

3-Month Chart

FBIO 3-Month Chart

1-Month Chart

FBIO 1-Month Chart

1-Day Chart

FBIO 1-Day Chart

IMUC
Data Last Updated: More than 2 wks ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 893,213


P/E: N/A

P/S: N/A

Q P/B: 0

Y Rev: -

Q Rev: -

Beta: 2.90

IMUC Share Stats

Outstanding Shares

41.93M

Float Shares

41.75M

Percent of Float Short

N/A

IMUC Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

IMUC Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

IMUC in Pulse Portal

Stream of Posts

IMUC Symbol Page

Share IMUC Insights

Express Sentiment

'Buy' or 'Sell' IMUC

IMUC Profile

CEO

Dr. John S. Yu

Exchange

OTC

Employees

4.00

About

ImmunoCellular Therapeutics, Ltd. is a clinical-stage company, which engages in the development of immune-based therapies for the treatment of cancers. The company's lead product candidate, ICT-107, is a dendritic cell-based immunotherapy targeting multiple tumor-associated...

IMUC Financials

Annual Financials

Income Statement

Revenue

-

Net Income

(14.35M)

Cash Flow Statement

Change in Cash / Investments

(4.81M)

Balance Sheet

Cash / Investments

6.63M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

7.01M

Total Current Liabilities

2.36M

Total Assets

7.01M

Total Liabilities

2.36M

Stockholder Equity

4.65M

Quarterly Financials

Income Statement

Q Revenue

-

Q Net Income

(306,704)

Cash Flow Statement

Q Change in Cash / Investments

(2.17M)

Balance Sheet

Q Cash / Investments

2.85M

Q Short Term Debt

None

Q Long Term Debt

None

Q Total Current Assets

3.83M

Q Total Current Liabilities

401,944

Q Total Assets

3.83M

Q Total Liabilities

401,944

Q Stockholder Equity

3.43M

IMUC Charts

10-Year Chart

IMUC 10-Year Chart

5-Year Chart

IMUC 5-Year Chart

1-Year Chart

IMUC 1-Year Chart

6-Month Chart

IMUC 6-Month Chart

3-Month Chart

IMUC 3-Month Chart

1-Month Chart

IMUC 1-Month Chart

1-Day Chart

IMUC 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon